BEC Chemicals Pvt. Ltd.

becchemicals.com

BEC Chemicals Pvt. Ltd specializes in manufacturing of Active pharmaceutical Ingredients (API’s) and Intermediates. The manufacturing unit in Roha (Raigad dist.) has been approved by Indian and European Drug Authority and is EU-GMP, WHO-GMP and State GMP certified. The company is ISO 9001:2008, 14001:2004, 18000:2007, OHSAS certified by SGS-UK. The manufacturing unit is a 100% Export Oriented Unit and is recognized as STAR EXPORT house by DGFT (INDIA). Recently we have been approved by USFDA.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights, PHARMA TECH

SIMULATIONS PLUS ENTERS NEW STRATEGIC COLLABORATION TO DISCOVER ANTICANCER THERAPIES THROUGH ITS AI-DRIVEN DRUG DESIGN TECHNOLOGY

Businesswire | March 29, 2023

news image

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF). This collaboration will leverage Simulations Plus’ staff and Artificial Intelligence-driven Drug Design technology in the ADMET Predictor® software platform to support the discovery and design of novel inhibitors of methylenetetrahyd...

Read More

PHARMACY MARKET, PHARMA TECH

CAPSIDA BIOTHERAPEUTICS AND ABBVIE ANNOUNCE EXPANSION OF COLLABORATION

Capsida Biotherapeutics | February 27, 2023

news image

Capsida Biotherapeutics Inc., a fully integrated next-generation gene therapy platform company, and AbbVie, a pharmaceutical company dedicated to discovering and providing innovative medicines to address serious health issues, have recently announced an expanded strategic collaboration. The collaboration aims to develop genetic medicines for eye diseases with high unmet needs. Capsida's novel adeno-associated virus (AAV) engineering platform and manufacturing capability will...

Read More

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

news image

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More

Pharma Tech

THE IMA GROUP ANNOUNCES ACQUISITION OF REDLINK, INC., A SOCIAL SECURITY DISABILITY EVALUATION COMPANY

IMA Group | January 27, 2022

news image

Extending its service area to seven new states and strengthening it in seven existing markets, The IMA Group (IMA) announced today the acquisition of Redlink, Inc., a regional provider of Social Security Disability evaluations currently operating in the Western United States. The acquisition continues IMA’s long-standing commitment to providing quality Social Security Disability Consultative Examinations (CEs) and positions it to further expand its portfolio of service offerings in rapidly...

Read More
news image

Business Insights, PHARMA TECH

SIMULATIONS PLUS ENTERS NEW STRATEGIC COLLABORATION TO DISCOVER ANTICANCER THERAPIES THROUGH ITS AI-DRIVEN DRUG DESIGN TECHNOLOGY

Businesswire | March 29, 2023

Simulations Plus, Inc. a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation (SACF). This collaboration will leverage Simulations Plus’ staff and Artificial Intelligence-driven Drug Design technology in the ADMET Predictor® software platform to support the discovery and design of novel inhibitors of methylenetetrahyd...

Read More
news image

PHARMACY MARKET, PHARMA TECH

CAPSIDA BIOTHERAPEUTICS AND ABBVIE ANNOUNCE EXPANSION OF COLLABORATION

Capsida Biotherapeutics | February 27, 2023

Capsida Biotherapeutics Inc., a fully integrated next-generation gene therapy platform company, and AbbVie, a pharmaceutical company dedicated to discovering and providing innovative medicines to address serious health issues, have recently announced an expanded strategic collaboration. The collaboration aims to develop genetic medicines for eye diseases with high unmet needs. Capsida's novel adeno-associated virus (AAV) engineering platform and manufacturing capability will...

Read More
news image

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More
news image

Pharma Tech

THE IMA GROUP ANNOUNCES ACQUISITION OF REDLINK, INC., A SOCIAL SECURITY DISABILITY EVALUATION COMPANY

IMA Group | January 27, 2022

Extending its service area to seven new states and strengthening it in seven existing markets, The IMA Group (IMA) announced today the acquisition of Redlink, Inc., a regional provider of Social Security Disability evaluations currently operating in the Western United States. The acquisition continues IMA’s long-standing commitment to providing quality Social Security Disability Consultative Examinations (CEs) and positions it to further expand its portfolio of service offerings in rapidly...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us